Anxiety associated with comorbid depression

Journal of Clinical Psychiatry

Volumn 63, Issue SUPPL. 14, 2002, Pages 22-26

  Möller, Hans Jürgen ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; FLUOXETINE; IMIPRAMINE; LORAZEPAM; PLACEBO;

ALGORITHM; ANXIETY DISORDER; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMORBIDITY; DEPRESSION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG EFFICACY; DRUG INDICATION; DRUG MISUSE; HAMILTON SCALE; HUMAN; META ANALYSIS; MONOTHERAPY; PANIC; PREVALENCE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SLEEP DISORDER; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; ALGORITHMS; ALPRAZOLAM; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; BENZODIAZEPINES; CLINICAL TRIALS; COMORBIDITY; DECISION TREES; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG THERAPY, COMBINATION; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0036907810     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
3. Kessler RC, Nelson CB, McGonagle KA, et al. Comorbidity of DSM-III-R major depressive disorder in the general population: Results from the US National Comorbidity Survey. Br J Psychiatry 1996;168(suppl 30):17-30
4. Wittchen H-U, Zhao S, Kessler RC, et al. DSM-III-R generalized anxiety disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51:355-364
5. Stein MB, Kirk P, Prabhu V, et al. Mixed anxiety-depression in a primary-care clinic. J Affect Disord 1995;34:79-84
6. Sartorius N, Ustun TB, Lecrubier Y, et al. Depression comorbid with anxiety: Results from the WHO study on psychological disorders in primary health care. Br J Psychiatry 1996;168(suppl 30):38-43
7. Lydiard RB, Brawman-Mintzer O. Anxious depression. J Clin Psychiatry 1998;59(suppl 18):10-17
8. Clayton PJ, Grove WM, Coryell W, et al. Follow-up and family study of anxious depression. Am J Psychiatry 1991;148:1512-1517
9. Furukawa TA, Streiner DL, Young LT. Is antidepressant-benzodiazepine combination therapy clinically more useful? A meta-analytic study. J Affect Disord 2001;65:173-177
10. Smith WT, Londborg PD, Glaudin V, et al. Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: A double-blind study. Am J Psychiatry 1998;155:1339-1345
11. Londborg PD, Smith WT, Glaudin V, et al. Short-term cotherapy with clonazepam and fluoxetine: Anxiety, sleep disturbance, and core symptoms of depression. J Affect Disord 2000;61:73-79
12. Laakman G, Faltermaier-Temizel M, Bossert-Zaudig S, et al. Treatment of depressive outpatients with lorazepam, alprazolam, amitriptyline, and placebo. Psychopharmacology (Berl) 1995;120:109-115
13. Laakmann G, Blaschke D, Hippius H, et al. Alprazolam versus amitriptyline in the treatment of depressed out-patients: A randomized double-blind trial. In: Lader, Davies HC, eds. Drug Treatment of Neurotic Disorders. Edinburgh, Scotland: Churchill Livingstone; 1986:129-136
14. Srisurapanont M, Boonyanaruthee V. Alprazolam and standard antidepressants in the treatment of depression: A meta-analysis of the antidepressant effect. J Med Assoc Thai 1997;80:183-188
15. Petty F, Trivedi MH, Fulton M, et al. Benzodiazepines as antidepressants: Does GABA play a role in depression? Biol Psychiatry 1995;38:578-591
16. Birkenhager TK, Moleman P, Nolen WA. Benzodiazepines for depression? A review of the literature. Int Clin Psychopharmacol 1995;10:181-195
17. Keller MB, Lavori PW, Goldenberg IM, et al. Influence of depression on the treatment of panic disorder with imipramine, alprazolam, and placebo. J Affect Disord 1993;28:27-38
18. Klerman GL. Depression and panic anxiety: The effect of depressive comorbidity on response to drug treatment of patients with panic disorder and agoraphobia. J Psychiatr Res 1990;24(suppl 2):27-41